| scholarly article | Q13442814 |
| P2093 | author name string | K Schmiegelow | |
| M Pulczynska | |||
| P2860 | cites work | Methotrexate hepatotoxicity in children with leukemia | Q28331928 |
| Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems | Q33809314 | ||
| Evaluation of survival data and two new rank order statistics arising in its consideration | Q34054360 | ||
| Are children with lymphoblastic leukaemia given enough 6-mercaptopurine? | Q39464219 | ||
| Clinical pharmacokinetics of methotrexate in psoriasis therapy | Q39837148 | ||
| Physician compliance and relapse rates of acute lymphoblastic leukemia in children | Q48106955 | ||
| Hepatic ultrastructure in leukemic children treated with methotrexate and 6-mercaptopurine. | Q52502340 | ||
| Increase of dihydrofolate reductase in peripheral blood lymphocytes of rheumatoid arthritis patients treated with low-dose oral methotrexate. | Q54408977 | ||
| Hepatotoxicity in the treatment of acute lymphoblastic leukaemia | Q66869985 | ||
| The pharmacology of orally administered chemotherapy. A reappraisal | Q68727552 | ||
| The effect of methotrexate on the bioavailability of oral 6-mercaptopurine | Q68753926 | ||
| Biochemical parameters of mercaptopurine activity in patients with acute lymphoblastic leukemia | Q68952056 | ||
| Methodologic guidelines for reports of clinical trials | Q70048940 | ||
| Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol | Q70920774 | ||
| Antineoplastic agents and the liver | Q71127718 | ||
| Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy | Q71980237 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| leukemia | Q29496 | ||
| hepatotoxicity | Q1349821 | ||
| P304 | page(s) | 767-772 | |
| P577 | publication date | 1990-05-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia | |
| P478 | volume | 61 |
| Q38015163 | Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma. |
| Q54566243 | Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. |
| Q46844249 | Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy |
| Q27023839 | Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction |
| Q33874582 | Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism |
| Q45985775 | Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens. |
| Q67840023 | Prognostic Significance of Methotrexate and 6-Mercaptopurine Dosage During Maintenance Chemotherapy for Childhood Acute Lymphoblastic Leukemia |
| Q41762842 | TPMT in the treatment of Crohn's disease with azathioprine |
| Q34265967 | The clinical pharmacology of 6-mercaptopurine |
| Q45403433 | The rate of hepatitis B and C virus infections and the importance of HBV vaccination in children with acute lymphoblastic leukemia |
| Q36988021 | Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia |
| Q36747429 | Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing |
Search more.